Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:3547-3551
Published online before print August 20, 2009, doi: 10.1161/STROKEAHA.109.562769
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/11/3547    most recent
STROKEAHA.109.562769v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Rizos, T.
Right arrow Articles by Veltkamp, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rizos, T.
Right arrow Articles by Veltkamp, R.
Related Collections
Right arrow Coumarins
Right arrow Other diagnostic testing
Right arrow Acute Cerebral Infarction
Right arrow Embolic stroke
Right arrow Thrombolysis

(Stroke. 2009;40:3547.)
© 2009 American Heart Association, Inc.


Original Contributions

Point-of-Care International Normalized Ratio Testing Accelerates Thrombolysis in Patients With Acute Ischemic Stroke Using Oral Anticoagulants

Timolaos Rizos, MD; Christian Herweh, MD; Ekkehart Jenetzky, MD; Christoph Lichy, MD, MSc; Peter Arthur Ringleb, MD; Werner Hacke, MD, PhD Roland Veltkamp, MD

From Department of Neurology (T.R., C.L., P.A.R., W.H., R.V.), University of Heidelberg, Germany; Department of Neuroradiology (C.H.), University of Heidelberg, Germany; and Department of Clinical Epidemiology and Aging Research (E.J.), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Correspondence to Roland Veltkamp, MD, Department of Neurology, University Heidelberg, INF 400, 69120 Heidelberg. Germany. E-mail Roland.Veltkamp{at}med.uni-heidelberg.de

Background and Purpose— Thrombolysis in patients using oral anticoagulants (OAC) and in patients for whom information on OAC status is not available is frequently delayed because the standard coagulation analysis procedure in central laboratories (CL) is time-consuming. By using point-of-care (POC) coagumeters, international normalized ratio (INR) values can be measured immediately at the bedside. The accuracy and effectiveness of POC devices for emergency management in acute ischemic stroke has not been tested.

Methods— In phase 1, the reliability of emergency INR POC measurements in comparison to CL was determined. In phase 2, patients with ischemic stroke admitted within the time frame for systemic thrombolysis and who were either using OAC or for whom information on OAC status was not available were enrolled. Patients received thrombolysis if POC INR was ≤1.5. Precision and time gain was recorded for INR as measured by POC vs CL.

Results— In phase 1 (n=113), Bland-Altman analysis showed close agreement between POC and CL, and Pearson correlation was highly significant (r=0.98; P<0.01). In phase 2, 48 patients were included, of whom 70.8% were using OAC; 23 patients received thrombolysis. After subtracting the time needed for the diagnostic work-up, the net time gain was 28±12 minutes (mean±SD).

Conclusions— Measuring INR by POC in an emergency setting is sufficiently precise in OAC acute stroke patients and substantially reduces the time interval until INR values are available and therefore may hasten the initiation of thrombolysis.


Key Words: acute ischemic stroke • emergency room • INR • oral anticoagulants • point of care • thrombolysis